PT3937948T - Fitoecdisonas e seus derivados para utilização no tratamento de doenças neuromusculares - Google Patents
Fitoecdisonas e seus derivados para utilização no tratamento de doenças neuromuscularesInfo
- Publication number
- PT3937948T PT3937948T PT207095944T PT20709594T PT3937948T PT 3937948 T PT3937948 T PT 3937948T PT 207095944 T PT207095944 T PT 207095944T PT 20709594 T PT20709594 T PT 20709594T PT 3937948 T PT3937948 T PT 3937948T
- Authority
- PT
- Portugal
- Prior art keywords
- phytoecdysones
- derivatives
- treatment
- neuromuscular diseases
- neuromuscular
- Prior art date
Links
- 208000018360 neuromuscular disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1902726A FR3093640B1 (fr) | 2019-03-15 | 2019-03-15 | Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3937948T true PT3937948T (pt) | 2024-01-02 |
Family
ID=67660223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT207095944T PT3937948T (pt) | 2019-03-15 | 2020-03-12 | Fitoecdisonas e seus derivados para utilização no tratamento de doenças neuromusculares |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220160732A1 (pt) |
| EP (1) | EP3937948B1 (pt) |
| JP (1) | JP2022525228A (pt) |
| KR (1) | KR20210141579A (pt) |
| CN (1) | CN113766920A (pt) |
| BR (1) | BR112021018222A2 (pt) |
| CA (1) | CA3133227A1 (pt) |
| DK (1) | DK3937948T3 (pt) |
| ES (1) | ES2966716T3 (pt) |
| FR (1) | FR3093640B1 (pt) |
| MX (1) | MX2021011151A (pt) |
| PL (1) | PL3937948T3 (pt) |
| PT (1) | PT3937948T (pt) |
| WO (1) | WO2020187678A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
| FR3128873A1 (fr) | 2021-11-10 | 2023-05-12 | Biophytis | Phytoecdysones et/ou dérivés de 20-hydroxyecdysone en combinaison avec un principe actif visant à restaurer l’expression SMN pour leur utilisation dans le traitement de l’amyotrophie spinale |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004137207A (ja) * | 2002-10-18 | 2004-05-13 | Keio Gijuku | 細胞毒性を抑制する蛋白質 |
| ES2632431T3 (es) * | 2009-10-30 | 2017-09-13 | Ntf Therapeutics, Inc. | Moléculas de neurturina mejoradas |
| FR3021318B1 (fr) * | 2014-05-20 | 2017-04-28 | Inst Biophytis | Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments |
| US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
| FR3065644B1 (fr) * | 2017-04-28 | 2020-02-21 | Biophytis | Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation |
-
2019
- 2019-03-15 FR FR1902726A patent/FR3093640B1/fr active Active
-
2020
- 2020-03-12 JP JP2021555793A patent/JP2022525228A/ja active Pending
- 2020-03-12 PL PL20709594.4T patent/PL3937948T3/pl unknown
- 2020-03-12 US US17/439,681 patent/US20220160732A1/en active Pending
- 2020-03-12 KR KR1020217033355A patent/KR20210141579A/ko unknown
- 2020-03-12 ES ES20709594T patent/ES2966716T3/es active Active
- 2020-03-12 PT PT207095944T patent/PT3937948T/pt unknown
- 2020-03-12 EP EP20709594.4A patent/EP3937948B1/fr active Active
- 2020-03-12 DK DK20709594.4T patent/DK3937948T3/da active
- 2020-03-12 BR BR112021018222A patent/BR112021018222A2/pt unknown
- 2020-03-12 MX MX2021011151A patent/MX2021011151A/es unknown
- 2020-03-12 CN CN202080032581.0A patent/CN113766920A/zh active Pending
- 2020-03-12 WO PCT/EP2020/056590 patent/WO2020187678A1/fr active Application Filing
- 2020-03-12 CA CA3133227A patent/CA3133227A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113766920A (zh) | 2021-12-07 |
| FR3093640A1 (fr) | 2020-09-18 |
| EP3937948A1 (fr) | 2022-01-19 |
| BR112021018222A2 (pt) | 2021-11-23 |
| WO2020187678A1 (fr) | 2020-09-24 |
| US20220160732A1 (en) | 2022-05-26 |
| CA3133227A1 (fr) | 2020-09-24 |
| PL3937948T3 (pl) | 2024-04-08 |
| MX2021011151A (es) | 2022-01-19 |
| ES2966716T3 (es) | 2024-04-23 |
| KR20210141579A (ko) | 2021-11-23 |
| DK3937948T3 (da) | 2024-01-08 |
| EP3937948B1 (fr) | 2023-09-27 |
| JP2022525228A (ja) | 2022-05-11 |
| FR3093640B1 (fr) | 2021-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3377637T (lt) | Kompozicijos, skirtos panaudoti žaizdų, sutrikimų ir odos ligų gydymo būduose | |
| IL288214A (en) | Quinazolin-4-one derivatives are useful for the treatment of braf-related diseases and disorders | |
| IL284125A (en) | History of quinoline for use in the treatment of inflammatory diseases | |
| IL289167A (en) | The history of 2h-indazole and their use in the treatment of diseases | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| ZA201902910B (en) | Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer | |
| IL287796A (en) | Preparations and methods for the treatment of diseases mediated by ATPase | |
| EP3969125A4 (en) | USE OF ANTI-FCRN ANTIBODIES IN THE TREATMENT OF PEMPHIGHUS AND PEMPHIGOID DISEASES | |
| IL289289A (en) | History of polyaromatic ureas and their use in the treatment of muscle diseases | |
| PL3937948T3 (pl) | Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu chorób nerwowo-mięśniowych | |
| IL291388A (en) | Heterocyclic derivatives, pharmaceutical preparations and their use for the treatment or alleviation of cancer | |
| ZA201903828B (en) | Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| PL3937949T3 (pl) | Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych | |
| PL3515409T3 (pl) | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| IL286649A (en) | The history of quinoline and its use in cancer treatment | |
| GB2574747B (en) | Use of lambda interferons in the treatment of obesity-related disorders and related diseases | |
| GB2603379B (en) | Avocatin B for the treatment of diseases and conditions | |
| GB201817346D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of diseases | |
| RS64967B1 (sr) | Kompozicija za upotrebu u prevenciji i/ili lečenju osteoartikularnih bolesti | |
| EP4025304C0 (en) | THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER | |
| GB201901871D0 (en) | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases | |
| GB201718838D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| GB201712742D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |